Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Published:2007-01-01 Issue:5 Volume:41 Page:422-429
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Masumori Naoya¹,Hashimoto Jiro¹,Itoh Naoki¹,Tsukamoto Taiji¹,The Sapporo Medical University Naftopidil Study Group ¹

Affiliation:

1. Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365590701226036

Reference22 articles.

1. AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and Treatment Recommendations

2. Long-term Safety and Efficacy of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

3. LONG-TERM USE OF TAMSULOSIN TO TREAT LOWER URINARY TRACT SYMPTOMS/BENIGN PROSTATIC HYPERPLASIA

4. Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive Patients

5. Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil;Urology Annals;2021

2. Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study;PLOS ONE;2019-07-25

3. Pre-treatment serum testosterone level can be a useful factor to predict the improvement in bladder outlet obstruction by tadalafil for male patients with lower urinary tract symptoms induced by benign prostatic obstruction;The Aging Male;2019-01-16

4. What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?;Urologia Internationalis;2019

5. Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study;International Journal of Urology;2018-08-01